Evaluation of the HFA-PEFF Score: results from the prospective DIAST-CHF cohort

被引:11
作者
Hashemi, Djawid [1 ,2 ,3 ]
Mende, Meinhard [4 ,5 ]
Trippel, Tobias D. [1 ,3 ]
Petutschnigg, Johannes [1 ,3 ]
Hasenfuss, Gerd [6 ,7 ]
Nolte, Kathleen [6 ,7 ]
Herrmann-Lingen, Christoph [6 ,8 ]
Feuerstein, Anna [1 ,3 ]
Langhammer, Romy [9 ]
Tschope, Carsten [1 ,3 ,10 ,11 ]
Pieske, Burkert [1 ,2 ,3 ]
Wachter, Rolf [6 ,9 ]
Edelmann, Frank [1 ,3 ]
机构
[1] Charlie Univ Med Berlin, Campus Virchow Klinikum, Dept Internal Med & Cardiol, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] German Heart Inst Berlin DHZB, Dept Internal Med & Cardiol, Berlin, Germany
[3] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany
[4] Univ Leipzig, Clin Trial Ctr, Leipzig, Germany
[5] Univ Leipzig, Inst Med Informat Stat & Epidemiol IMISE, Leipzig, Germany
[6] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Berlin, Germany
[7] Georg August Univ, Dept Cardiol & Pneumol, Gottingen, Germany
[8] Univ Gottingen, Dept Psychosomat Med & Psychotherapy, Med Ctr, Gottingen, Germany
[9] Univ Hosp Leipzig, Clin & Policlin Cardiol, Leipzig, Germany
[10] Charlie Univ Med Berlin, Campus Virchow Klinikum, Berlin Inst Hlth BIH, Berlin, Germany
[11] Charlie Univ Med Berlin, Campus Virchow Klinikum, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany
来源
ESC HEART FAILURE | 2022年 / 9卷 / 06期
关键词
Heart failure; Heart failure with preserved ejection fraction; HFpEF; Prognosis; HFA-PEFF score; PRESERVED EJECTION FRACTION; HEART-FAILURE; RISK; DYSFUNCTION; ALGORITHMS; DIAGNOSIS; H2FPEF;
D O I
10.1002/ehf2.14131
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Although the number of patients suffering from heart failure with preserved ejection fraction (HFpEF) increases, the routine diagnosis remains a challenge. In the absence of a pathognomonic sign for HFpEF or specific treatment strategies, a prognosis-based characterization of suspected patients remains promising for both the risk stratification of the patients and a disease definition. The Heart Failure Association (HFA) of the European Society of Cardiology has introduced an algorithm with different levels of likelihood regarding the diagnosis of HFpEF, the HFA-PEFF score. We aimed to evaluate the predictive value of this algorithm in a large cohort regarding mortality, symptom burden, and the functional status. Methods and results DIAST-CHF is a multicentre, population-based, prospective, observational study in subjects with at least one risk factor for HFpEF between the age of 50 and 85. We calculated the HFA-PEFF score (n = 1668) and analysed the risk groups for overall mortality, cardiovascular hospitalization, and submaximal functional capacity (6-min walk distance) at baseline and after a follow-up period of 10 years. Patients with high HFA-PEFF score values 5&6 showed a higher mortality than those with an intermediate score (score values 2-4) and low score values (high 21.3% vs. intermediate 10.1% vs. low 4.3%, P < 0.001). Also, the burden of MACE (death, cardiovascular hospitalization, new myocardial infarction, first diagnosis of HF) was increased in the high score values group (high 40.7% vs. intermediate 25.9% vs. low 13.9%, P < 0.001). Similarly, patients with higher scores had higher cumulative incidences of cardiovascular hospitalizations (P = 0.011). Subjects with higher scores also had lower 6-min walk distance both at baseline and during follow-up. Conclusions The HFA-PEFF score provides a reliable instrument to stratify suspected HFpEF patients by their risk for mortality, symptom burden, and functional status in cohort at risk with a follow-up period of 10 years. As high HFA-PEFF scores are associated with worse outcome, the HFA-PEFF algorithm describes a defining approach towards HFpEF.
引用
收藏
页码:4120 / 4128
页数:9
相关论文
共 26 条
  • [1] Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction
    Aizpurua, Arantxa Barandiaran
    Sanders-van Wijk, Sandra
    Brunner-La Rocca, Hans-Peter
    Henkens, Michiel
    Heymans, Stephane
    Beussink-Nelson, Lauren
    Shah, Sanjiv J.
    van Empel, Vanessa P. M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (03) : 413 - 421
  • [2] The H2FPEF and HFA-PEFF algorithms for predicting exercise intolerance and abnormal hemodynamics in heart failure with preserved ejection fraction
    Amanai, Shiro
    Harada, Tomonari
    Kagami, Kazuki
    Yoshida, Kuniko
    Kato, Toshimitsu
    Wada, Naoki
    Obokata, Masaru
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure - The Rotterdam Study
    Bleumink, GS
    Knetsch, AM
    Sturkenboom, MCJM
    Straus, SMJM
    Hofman, A
    Deckers, JW
    Witteman, JCM
    Stricker, BHC
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (18) : 1614 - 1619
  • [4] Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
    Bobenko, Anna
    Duvinage, Andre
    Mende, Meinhard
    Holzendorf, Volker
    Nolte, Kathleen
    Herrmann-Lingen, Christoph
    Binder, Lutz
    Duengen, Hans-Dirk
    Hasenfuss, Gerd
    Pieske, Burkert
    Wachter, Rolf
    Edelmann, Frank
    [J]. IJC HEART & VASCULATURE, 2020, 28
  • [5] Validating the HFA-PEFF score - or how to define a disease?
    Coats, Andrew J. Stewart
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (03) : 428 - 431
  • [6] Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: Quality of life in diastolic dysfunction
    Edelmann, Frank
    Stahrenberg, Raoul
    Polzin, Friederike
    Kockskaemper, Anke
    Duengen, Hans-Dirk
    Duvinage, Andre
    Binder, Lutz
    Kunde, Jan
    Scherer, Martin
    Gelbrich, Goetz
    Hasenfuss, Gerd
    Pieske, Burkert
    Wachter, Rolf
    Herrmann-Lingen, Christoph
    [J]. AMERICAN HEART JOURNAL, 2011, 161 (04) : 797 - 804
  • [7] HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction
    Egashira, Koichi
    Sueta, Daisuke
    Komorita, Takashi
    Yamamoto, Eiichiro
    Usuku, Hiroki
    Tokitsu, Takanori
    Fujisue, Koichiro
    Nishihara, Taiki
    Oike, Fumi
    Takae, Masafumi
    Hanatani, Shinsuke
    Takashio, Seiji
    Ito, Miwa
    Yamanaga, Kenshi
    Araki, Satoshi
    Soejima, Hirofumi
    Kaikita, Koichi
    Matsushita, Kenichi
    Tsujita, Kenichi
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (01) : 96 - +
  • [8] Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort
    Haarmann, Helge
    Koch, Jennifer
    Bonsch, Nina
    Mende, Meinhard
    Werhahn, Stefanie Maria
    Lueers, Claus
    Stahrenberg, Raoul
    Edelmann, Frank
    Holzendorf, Volker
    von Haehling, Stephan
    Pieske, Burkert
    Andreas, Stefan
    Luethje, Lars
    Wachter, Rolf
    [J]. RESPIRATORY MEDICINE, 2019, 154 : 127 - 132
  • [9] Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany
    Hashemi, Djawid
    Blum, Moritz
    Mende, Meinhard
    Stoerk, Stefan
    Angermann, Christiane E.
    Pankuweit, Sabine
    Tahirovic, Elvis
    Wachter, Rolf
    Pieske, Burkert
    Edelmann, Frank
    Duengen, Hans-Dirk
    [J]. ESC HEART FAILURE, 2020, 7 (03): : 942 - 952
  • [10] HOLM S, 1979, SCAND J STAT, V6, P65